Next Article in Journal
Proteomics Analysis of Lymphoblastoid Cell Lines from Patients with Amyotrophic Lateral Sclerosis
Previous Article in Journal
Toxicity and Physiological Effects of Nine Lamiaceae Essential Oils and Their Major Compounds on Reticulitermes dabieshanensis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 28
Issue 5
10.3390/molecules28052013
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Brief History, Preparation Method, and Biological Application of Mesoporous Silica Molecular Sieves: A Narrative Review

by
Qiuping Li
1,2,3,* and
You Zhou
4,*
1
School of Pharmacy, Fuzhou Medical College of Nanchang University, Fuzhou 344000, China
2
Key Laboratory of Chronic Diseases, Fuzhou Medical College of Nanchang University, Fuzhou 344000, China
3
Technology Innovation Center of Chronic Disease Research in Fuzhou City, Fuzhou Science and Technology Bureau, Fuzhou 344000, China
4
State Key Laboratory Base of Novel Functional Materials and Preparation Science, School of Materials Science and Chemical Engineering, Ningbo University, Ningbo 315211, China
*
Authors to whom correspondence should be addressed.
Molecules 2023, 28(5), 2013; https://doi.org/10.3390/molecules28052013
Submission received: 26 January 2023 / Revised: 14 February 2023 / Accepted: 19 February 2023 / Published: 21 February 2023
Browse Figures
Review Reports Versions Notes

Abstract

:
It has been more than 30 years since the first ordered mesoporous silica molecular sieve (MCM-41) was reported, but the enthusiasm for exploiting mesoporous silica is still growing due to its superior properties, such as its controllable morphology, excellent hosting capability, easy functionalization, and good biocompatibility. In this narrative review, the brief history of the discovery of mesoporous silica and several important mesoporous silica families are summarized. The development of mesoporous silica microspheres with nanoscale dimensions, hollow mesoporous silica microspheres, and dendritic mesoporous silica nanospheres is also described. Meanwhile, common synthesis methods for traditional mesoporous silica, mesoporous silica microspheres, and hollow mesoporous silica microspheres are discussed. Then, we introduce the biological applications of mesoporous silica in fields such as drug delivery, bioimaging, and biosensing. We hope this review will help people to understand the history of the development of mesoporous silica molecular sieves and become familiar with their synthesis methods and applications in biology.

1. Introduction

Porous materials have been widely used for thousands of years. One of the most well-known materials in this category is activated carbon, which is commonly used as an adsorbent [1,2,3]. Over the past few decades, porous materials, especially nano-scale porous materials, have received widespread attention due to their large surface area, open structure, and so on [4,5,6,7]. Well-established nanoporous materials include mesoporous silica molecular sieves [8], zeolite molecular sieves [9], metal–organic frameworks [10], covalent organic frameworks [11], nanoporous carbon [12], etc. Among these, mesoporous silica molecular sieves have stood out in the field of biological applications because of their adjustable pore size, easy functionalization, high stability, and physiological inertia [13,14,15]. According to the IUPAC nomenclature rules, mesoporous materials usually refer to materials with a pore size between 2 and 50 nm. Moderate-sized apertures ensure that mesoporous silica molecular sieves have a large surface area and are easy to fill with various materials. Additionally, the non-toxic properties of silica have been approved by the FDA (Food and Drug Administration) and EFSA (European Food Safety Authority), and related materials are widely used in the cosmetics and food additive industries [16,17,18,19]. Thus, mesoporous silica molecular sieves have great application potential as a carrier in drug delivery [20], bioimaging [21], biosensing [22], materials, etc., and have become one of the most important materials in the field of biological applications.

2. History of Mesoporous Silica Molecular Sieves

The first reported mesoporous silica was discovered by Yanagisawa et al. [23] in 1990. They synthesized an alkyltrimethylammonium–kanemite complex by reacting single-layered polysilicate kanemite with alkyltrimethylammonium chloride solutions, and they found that the SiO2 layers in the complexes condensed to form three-dimensional SiO2 networks. Two years later (1992), Kresge et al. [24,25] reported a novel ordered self-assembled mesoporous silica molecular sieve prepared by means of a template method, in which the silicate material forms inorganic walls via the hydrolysis polycondensation of tetramethylammonium silicate between ordered surfactant micelles. As they worked in Mobil Corporation Laboratories, they named this mesoporous silica MCM-41 (Mobil Composition of Matter No. 41), and it has been widely circulated since then. Kresge et al. [26,27,28,29] then extended their research to the M41S family of mesoporous molecular sieves, and found that the pore diameter, shape, and connectivity of M41S could be manipulated by controlling the structure and size of surfactant molecules. As scientific breakthroughs always bring booming development in related fields, this surfactant-based template method was soon found to be useful for the synthesis of other ordered mesoporous materials [30,31,32].
Since then, inspired by Kresge’s work, many new families of mesoporous silica materials have been reported by researchers all over the world. For example, to increase silica’s pore size, Zhao et al. [33] (1998) introduced an amphiphilic triblock copolymer with larger molecules as a template agent, and obtained an ordered hexagonal mesoporous silica structure. The resulting mesoporous silica, which was developed at the University of California, Santa Barbara, was denoted as SBA-15, which comes from the abbreviation of “Santa Barbara Amorphous No. 15”. Compared with MCM-41, SBA-15 has the advantages of a larger pore diameter, a thicker pore wall, and better hydrothermal stability, which provide it with wider application prospects. Since its development, the shining SBA family of mesoporous molecular sieves has gradually become one of the hottest research subjects in the field of mesoporous materials [34,35,36,37,38].
Alongside the M41s and SBA families, other important mesoporous silica families include the HMS family [39], FSM family [40], MSU family [41], KIT family [42], FDU family [43], JLU family [44], TUD family [45], COK family [46], HMM family [47], and so on. Key information about the origin of these mesoporous silica families is provided in Table 1. In addition to exploring the synthesis of mesoporous silica, researchers have also conducted significant research on its possible applications.
The ideal mesoporous silica for biological applications usually has a moderate pore size (less than 200 nm) and large surface area. With this in mind, researchers have focused their attention on synthesizing mesoporous silica microspheres with nanoscale dimensions. In 1997, Grun et al. [48] reported for the first time the synthesis of submicron spherical MCM-41 particles using a modified Stöber method, which involved adding a cationic surfactant as a template. Before long, Cai et al. [49] obtained spherical MCM-41 particles with an average size of 110 nm by reacting the extremely dilute solution of CTAB with TEOS in a sodium hydroxide medium at 353 K. Kobler et al. [50,51,52] prepared a series of MCM-like near-spherical silica particles with relatively uniform particle sizes between 40 and 150 nm via altering the incorporated functional group and the amount of TEA added in the synthesis. Although mesoporous silica has an abundant number of pores, there are continuous efforts to increase its volume. Some researchers have attempted to add hollow structures to the mesoporous silica to achieve this [53,54,55]. Zhu et al. [56] reported for the first time the synthesis of hollow mesoporous silica spheres via penetrating pore channels across the shells using PVP and CTAB as co-templates, which are uniform in size and have a high drug storage capacity. Another requirement for biological applications is that the material be degradable in vivo. To meet this requirement, Zhao’s group [57] invented a novel monodispersed three-dimensional dendritic mesoporous silica nanosphere that not only had tunable pore size and thickness, but were also biodegradable in simulated body fluid. As shown in Figure 1, the dendritic mesoporous silica nanosphere had a highly uniform particle size and mesostructures, making it a very attractive material for various applications.

3. Preparation Methods

As noted earlier, the first ordered mesoporous silica (MCM-41) was synthesized by means of a liquid crystal templating method. Usually, a typical lyotropic liquid crystal template can be prepared by mixing water and surfactant. The synthesis of MCM-41 is based on a silica skeleton precipitated around a lyotropic liquid crystal template formed by mixing quaternary ammonium surfactant with water. In fact, the synthesis of mesoporous silica is usually carried out via a liquid crystal templating method. Template-assisted technology has long been the most utilized method for the synthesis of ordered mesoporous materials, and various surfactant molecules can be used as templates to direct the synthesis of mesoporous silica [58,59,60]. As the liquid crystal template is not a solid template, a method called “soft-matter templating” is often used, and at times the endotemplate method [61]. In general, the structure of the liquid crystal template strongly depends on the conditions in the solution, such as the pH, temperature, and the concentration [62].
The discovery of MCM-41 promoted research on mesoporous silica materials. Since then, efforts have been made to uncover the exact mechanism behind the formation of mesoporous silica. Narayan et al. [63] clearly demonstrated the formation mechanism of MCM-41 (Figure 2). In addition to the liquid crystal templating mechanism, the synthesis of MCM-41 also involves a sol–gel process wherein the polymerization of silica is carried out around the micelles. Once the silica settles, the porosity can be obtained after the removal of the template from the mesostructured solid via calcination or solvent extraction. Most other types of mesoporous silica have similar synthesis processes. Thus, a typical synthesis process for mesoporous silica can be divided into three steps: (i) choosing an appropriate template and forming a liquid crystal template under certain conditions; (ii) adding the silicon source, waiting for the silica to settle completely around the surfactant micelles, and then performing an aging treatment; and (iii) finally, removing the template.
The original MCM-41 was synthesized in alkaline media and by means of a hydrothermal treatment. Generally, the synthesis is carried out under high temperature (≥100 °C) in an autoclave and requires a long crystallization time. Under certain conditions, the preparation of mesoporous silica can also be performed at room temperature [64,65,66]. In 1994, Huo et al. [67] reported room-temperature synthesis of mesoporous silica under acidic conditions for the first time. Compared to hydrothermal synthesis, the room temperature method is easy to carry out and does not require special equipment, which makes it more suitable for large-scale production. Although the room temperature method has many advantages, the crystallinity of mesoporous silica can be improved by increasing the temperature and pressure of the synthesis process within a certain range. Therefore, although it has been used for decades, the hydrothermal method remains the most efficient technique for the synthesis of mesoporous silica. Additionally, there are continuous efforts to prepare mesoporous silica with the high-temperature hydrothermal method in order to obtain mesoporous silica with unusual stability [68,69,70]. Xiao’s group [71] reported, for the first time, the synthesis of the mesoporous silica JLU-20 in strong acidic media at high temperatures (190 °C) using a mix of fluorocarbon and Pluronic P123 surfactants. Compared with the mesoporous silica prepared with the traditional method, the condensation degree of JLU-20 is higher, indicating a greatly improved thermal stability. Additionally, to further improve the synthetic efficiency, a microwave-assisted technique has been applied to the preparation of mesoporous silica [72,73,74]. It has been demonstrated that the microwave-assisted hydrothermal process has the advantages of a shorter reaction time, lower energy consumption, and more uniform product morphology compared to the conventional autoclave heating method.
Nanoscale mesoporous silica microspheres have attracted great interest because of their great potential for biological applications. The combination of the classical Stöber method and template method has been proven to be a successful strategy for the synthesis of mesoporous silica microspheres [75,76]. The typical Stöber process usually involves the hydrolysis and condensation of tetraethylorthosilicate (TEOS) in an alcohol–water mixture using an ammonia catalyst. In this process, monodisperse spherical silica can be obtained via a seed growth mechanism driven by surface tension. When the surfactant template is present, the particle growth process is accompanied by a cooperative self-assembly process, leading to the formation of spherical mesoporous silica. Recently, Garrido et al. [77] (Figure 3) proposed a reproducible “one-pot” method for the preparation of spherical mesoporous silica that could be functionalized with inorganic species based on a combination of the Atrane and the Stöber methods. This method simultaneously ensures the spherical morphology and dispersed degree of heterogeneous elements, which make it a critical technique for the synthesis of elemental functionalized spherical mesoporous silica.
Furthermore, the seed growth mechanism presented by Stöber has also been extended to prepare mesoporous silica microspheres under different conditions. For example, Pan et al. [78] reported the synthesis of mesoporous silica microspheres with uniform and tunable particle size by using hexadecyl trimethyl ammonium chloride as a template and triethanolamine (TEA) as an alkaline catalyst. The particle size of mesoporous silica microspheres can be tuned by changing the amount of TEA used. As shown in Figure 4, the obtained mesoporous silica microspheres are highly monodispersed and can be used for nuclear-targeted drug delivery.
In order to increase the loading capacity of these materials, efforts have been made to synthesize hollow mesoporous silica microspheres [79]. Soft templating methods such as the micelle templating method [80], microemulsion templating [81], etc., play an important role in the synthesis of hollow mesoporous silica microspheres. Han et al. [82] reported a series of mesoporous silica hollow spheres which were synthesized via a micelle and emulsion dual-templating route. The obtained particles had a diameter in the range of 80~220 nm, constant shell thickness of about 20 nm and constant mesopore size of about 4 nm. In particular, a hard templating method using polymer beads [83], silica colloids [84], or metal oxides [85] as the seed cores was developed to synthesize discrete, uniform, and monodisperse hollow mesoporous silica microspheres to meet the rigorous requirements of biological applications. For example, Wu et al. [86] reported a salt-assisted acid-etching strategy to prepare hollow mesoporous silica (Figure 5). The solid SiO2 core templates were prepared first via the classical Stöber process, and then pre-mixed TEOS and octadecyltrimethoxysilane (C18TMS) were added to the reaction system to promote the growth of the mesoporous shell around the solid SiO2 core. A salt-assisted acid strategy was then used to etch the solid SiO2 core of the SiO2@mSiO2. Further removal of the surfactant C18TMS provides highly uniform hollow mesoporous silica nanovehicles (HMSVs). With a similar process, and the addition of 1,4-bis(triethoxysily) benzene, an organosilica-functionalized SiO2@moSiO2 and HMOVs were subsequently obtained. The as-synthesized HMOVs were found to have high cargo-loading capacity and pH-responsive drug-releasing behavior due to their hollow structure and phenylene-bridged framework. This seed growth and core-etching method based on a colloidal solution of hard templates has been proven to be an effective strategy for the synthesis of hollow mesoporous silica microspheres by many research works in the past decade.
There are also many other novel approaches that have been proposed for the direct generation of mesoporous silica, such as the aerosol-based procedure [87], the biphase stratification approach [88,89,90], the evaporation-induced aggregating assembly method [91,92], and so on.

4. Biological Applications

Due to the chemical stability of SiO2 matrices, the abundant pores in mesoporous silica are an ideal vessel for a variety of molecules. Furthermore, the excellent biocompatibility of SiO2 matrices further broadens mesoporous silica’s application prospects in fields such as drug delivery, bioimaging, biosensing, and so on [93,94,95,96,97,98,99].
Vallet-Regi et al. [100] were pioneers in using mesoporous silica as a drug carrier. They firstly integrated ibuprofen into two MCM-41 materials with different pore sizes and subsequently examined the in vitro process of releasing the drug to a simulated body fluid. Since then, mesoporous silica has been widely used for drug delivery because of its high drug loading capacity, biocompatibility, and so on. Hollow mesoporous silica microspheres with a uniform particle size have become the most popular drug carrier [101,102,103,104]. Li et al. [105] (Figure 6) prepared mesoporous-silica-coated Au nanoparticles by employing gold nanoparticles (Au) as a core template and surfactant cetyltrimethyl ammonium bromide (CTAB) as the template directing mesoporous structure. After the CTAB and Au templates were removed via calcination and subsequently etching, hollow mesoporous silica nanoparticles were obtained and used to load doxorubicin hydrochloride (DOX), leading to a nanocapsule HMSN (Dox). It has been proven that the drug-releasing behavior of HMSNs (Dox) is consistent with the Fickian diffusion mechanism and can be tuned by adjusting the thickness of the mesoporous shell.
To meet the ever-increasing demand for precise treatment, drug delivery systems that can target diseased tissues are urgently needed [106,107,108]. For the treatment of cancer, in particular, a targeted controlled-release drug carrier can lower dosage, prolong drug duration, and prevent damage to healthy tissue. Chen et al. [109] reported multi-functional hollow mesoporous silica nanoparticles with enhanced drug delivery and in vivo imaging properties. As shown in Figure 7, the drug deliverer was prepared using a generally applicable surface engineering technique, and it had a uniform particle size. By grafting a CD105-targeting antibody on the surface of the particles, a 3-fold tumor uptake on average was achieved in 4T1 murine breast-tumor-bearing mice compared with the non-targeted group, as observed by a quantitative PET imaging study via chelating radioactive 64Cu to the particles and an in vivo NIRF imaging study via anchoring NIR dye on the particles. Furthermore, its hollow core confers on the drug carrier a 3~15-times-higher DOX loading capacity than that of carriers without a hollow structure, and its highest loading capacity was estimated to be 1129.2 mg/g. Their work showed that a diseased-tissue-targeted drug delivery system can be developed via the elaborated surface functionalization of mesoporous silica, suggesting that in vivo targeted cancer therapy can benefit from advances in mesoporous silica nanotechnology.
Researchers engaged in biological or medical research usually aim to analyze specific regions of cells or organisms through visual and clear images. To that end, numerous works have determined the biological information of cells, tissues, and even organisms directly by means of a non-invasive optical imaging technique [110,111,112,113]. Many of these studies are based on mesoporous silica functionalized by fluorophores, upconversion nanoparticles, etc. [114]. Typically, many fluorophores can be covalently grafted to a silica matrix via organo-bridged silane [115], while fluorescent inorganic compounds can be easily encapsulated by silica shells [116]. Kim et al. [117] reported a fluorescent probe prepared by covalently immobilizing rhodamine 6G onto mesoporous silica via the silane bridge; the resulting rhodamine 6G silica particle (RSSP) can be used as a fluorescent probe for the detection of Fe (III) and applications in bioimaging. Recently, Wu et al. [118] (Figure 8) prepared tri-dye-doped mesoporous silicon nanoparticles (MTP–MSNs) via the copolycondensation of dye-modified silane during the modified Stöber process. The resulting material can be used for multicolor cellular imaging basing on the FRET-based two-photon fluorescence mechanism. After the loading of DOX, the pores of MTP–MSNs were closed by AS1411 aptamer, which acted as both a pore-blocking agent and a targeting tumor agent. The resulting drug delivery system has a controlled release ability in vivo and was proven to be an ideal material for bioimaging and targeted therapy for specific cancers.
In general, the integration of sensing imaging abilities with drug delivery is a common topic of research [119,120,121]. For example, Yan et al. [122] (Figure 9) prepared two novel drug delivery nanovehicles with bovine serum albumin- or myoglobin-gated as well as upconverted nanoparticle-embedded mesoporous silica. The resulting UCNP@mSiO2 could be used for the controlled release of the encapsulated DOX when activated by tumor microenvironment stimuli such as an acidic pH, glutathione, or H2O2. In tests on tumor-bearing mice, these drug delivery nanovehicles showed a good inhibitory effect on tumor growth and negligible damage/toxicity to the normal tissues. Meanwhile, the DOX release behavior could be tracked in real time via monitoring the Förster resonance energy transfer between the UCNP cores and DOX.
Recently, stimuli-responsive drug delivery nanovehicles based on mesoporous silica have been widely studied for their ability to control drug release from pores under various stimuli, such as magnetism, ultrasound, light, and so on [123,124,125]. Li et al. [126] (Figure 10) synthesized a novel pH- and ultrasound-responsive DOX-releasing material based on polydopamine-coated mesoporous silica. The as-prepared DOX-loaded nanoparticles displayed a pH-related response induced by the degradation of polydopamine under acidic conditions, which triggers the release of encapsulated DOX from pores upon ultrasound exposure. Furthermore, it was observed that the nanoparticles could be used to inhibit the growth of tumor cells through the controlled release of DOX. Moreover, the nanoparticles possessed a photothermal effect due to NIR adsorption by the polydopamine layer, demonstrating their good potential for chemotherapy in cancer treatment.
Another important aspect in the biological applications of mesoporous silica relates to the development of novel hemostatic materials [127,128,129,130,131]. The high specific surface area of mesoporous silica enables it to rapidly absorb large amounts of water from the blood, causing a higher concentration of clotting factors and platelets and thus promoting hemostasis. For example, Zhang et al. [132] prepared a large-pore mesoporous silica particle that has a shorter blood clotting time in vitro than Celox™ granules. They further immobilized the mesoporous silica particle onto cotton fibers to form a mesoporous silica–cotton composite, which leads to a shorter blood clotting time and less blood loss than that seen with raw mesoporous silica powder in mouse bleeding models. In addition, mesoporous silica can also be doped with antibacterial drugs to prevent infections. Chen et al. [133] loaded tannic acid (TA), silver nanoparticles, and calcium ions onto mesoporous silica nanoparticles (MSNs) to prepare a novel biomaterial (Ca-TA-MSN@Ag) with the dual functions of hemostatic performance and antibacterial activity (Figure 11). The porosity of MSNs, TA molecules, and calcium ions could lead to a triple synergistic hemostatic effect, and so the time needed for Ca-TA-MSN@Ag to reach hemostasis is shorter than that for pure MSN. Furthermore, Ca-TA-MSN@Ag also showed excellent antibacterial activity due to having loaded Ag nanoparticles and TA molecules.

5. Conclusions

Since the discovery of mesoporous silica molecular sieves, their synthesis and application have attracted extensive attention from all over the world. This mini review briefly introduced the history of developmental and biological applications of mesoporous silica molecular sieves. Many significant families of mesoporous silica molecular sieves have been found, including M41s and SBA. The morphology of mesoporous silica has also developed from bulk materials to monodisperse nanoparticles, and some silica even has a hollow structure. Tuning the morphology of mesoporous silica can be achieved via the choice of molecular template or by adjusting the reaction parameters of the solution. By utilizing the well-known Stöber method, monodisperse mesoporous silica microspheres can be obtained. Furthermore, the combination of the seed growth mechanism originating from the Stöber method with a templating method can be used to develop hollow mesoporous silica microspheres with a higher hosting capacity. Additionally, the soft templating methods based on micelle or microemulsion play an important role in the synthesis of hollow mesoporous silica microspheres.
The properties of mesoporous silica molecular sieves, including a high biocompatibility, excellent hosting capability, etc., make them a popular carrier in biological applications. The most important application of mesoporous silicas is as a drug carrier. Generally, uniform spherical and hollow structures improve the drug loading and delivery capacities of mesoporous silica. Meanwhile, the incorporation of targeting, controlled release, and stimuli-responsive functions makes drug-loaded mesoporous silica promising for precision therapy. In addition, the functionalization of drug-loaded mesoporous silica with optical units, such as fluorophores, upconversion nanoparticles, etc., enables us to track the progress of drugs through a non-invasive bio-imaging technique. In the future, novel mesoporous silica-based drug delivery systems that combine functions such as targeting, stimuli responses, controlled release, and optical imaging will be of great significance in the field of disease treatment.

Author Contributions

Writing—original draft preparation, Q.L.; Writing—review and editing, Y.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Science and Technology Research Project of Jiangxi Provincial Department of Education (GJJ218108), the National Natural Science Foundation of China (21701092), the Natural Science Foundation of Zhejiang Province (LY21B010002), and the Natural Science Foundation of Ningbo (2021J105, 2022J104).

Institutional Review Board Statement

Not acceptable.

Informed Consent Statement

Not acceptable.

Data Availability Statement

Not acceptable.

Conflicts of Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Sample Availability

Samples of the compounds are not available from the authors.

References

  1. Mansour, F.; Al-Hindi, M.; Yahfoufi, R.; Ayoub, G.M.; Ahmad, M.N. The use of activated carbon for the removal of pharmaceuticals from aqueous solutions: A review. Rev. Environ. Sci. Bio/Technol. 2018, 17, 109–145. [Google Scholar] [CrossRef]
  2. Raut, E.R.; Thakur, A.B.; Chaudhari, A.R. Review on toxic metal ions removal by using activated carbon prepared from natural biomaterials. J. Phys. Conf. Ser. 2021, 1913, 12091. [Google Scholar] [CrossRef]
  3. Gopalan, J.; Buthiyappan, A.; Abdul Raman, A.A. Insight into metal-impregnated biomass based activated carbon for enhanced carbon dioxide adsorption: A review. J. Ind. Eng. Chem. 2022, 113, 72–95. [Google Scholar] [CrossRef]
  4. Mishra, R.; Militky, J.; Venkataraman, M. 7-nanoporous materials. In Nanotechnology in Textiles; Mishra, R., Militky, J., Eds.; Woodhead Publishing: Sawston, UK, 2019; pp. 311–353. [Google Scholar]
  5. Lu, G.Q.; Zhao, X.S. Nanoporous Materials: Science and Engineering; Imperial College Press: London, UK, 2004. [Google Scholar]
  6. Kianfar, E.; Sayadi, H. Recent advances in properties and applications of nanoporous materials and porous carbons. Carbon Lett. 2022, 32, 1645–1669. [Google Scholar] [CrossRef]
  7. Li, S.P.; Wu, Q.S.; Cui, C.; Lu, G.S.; Zhang, C.S.; Yan, Z.Y. Preparation of TiO2/Al-MCM-41 mesoporous materials from coal-series kaolin and photodegradation of methyl orange. Mater. Sci. 2013, 31, 372–377. [Google Scholar] [CrossRef]
  8. Jeelani, P.G.; Mulay, P.; Venkat, R.; Ramalingam, C. Multifaceted application of silica nanoparticles. A review. Silicon 2020, 12, 1337–1354. [Google Scholar] [CrossRef]
  9. Chen, L.H.; Sun, M.H.; Wang, Z.; Yang, W.M.; Xie, Z.K.; Su, B.L. Hierarchically structured zeolites: From design to application. Chem. Rev. 2020, 120, 11194–11294. [Google Scholar] [CrossRef]
  10. Pettinari, C.; Marchetti, F.; Mosca, N.; Tosi, G.; Drozdov, A. Application of metal-organic frameworks. Polym. Int. 2017, 66, 731–744. [Google Scholar] [CrossRef]
  11. Song, Y.P.; Sun, Q.; Aguila, B.; Ma, S.Q. Opportunities of covalent organic frameworks for advanced applications. Adv. Sci. 2019, 6, 1801410. [Google Scholar] [CrossRef] [Green Version]
  12. Liu, J.; Wickramaratne, N.P.; Qiao, S.Z.; Jaroniec, M. Molecular-based design and emerging applications of nanoporous carbon spheres. Nat. Mater. 2015, 14, 763–774. [Google Scholar] [CrossRef]
  13. Manzano, M.; Vallet-Regí, M. Mesoporous silica nanoparticles for drug delivery. Adv. Funct. Mater. 2020, 30, 1902634. [Google Scholar] [CrossRef]
  14. Li, Z.X.; Barnes, J.C.; Bosoy, A.; Stoddart, J.F.; Zink, J.I. Mesoporous silica nanoparticles in biomedical applications. Chem. Soc. Rev. 2012, 41, 2590–2605. [Google Scholar] [CrossRef] [PubMed]
  15. Huang, R.; Shen, Y.W.; Guan, Y.Y.; Jiang, Y.X.; Wu, Y.; Rahman, K.; Zhang, L.J.; Liu, H.J.; Luan, X. Mesoporous silica nanoparticles: Facile surface functionalization and versatile biomedical applications in oncology. Acta Biomater. 2020, 116, 1–15. [Google Scholar] [CrossRef] [PubMed]
  16. Efsa, P.O.F.A.; Younes, M.; Aggett, P.; Aguilar, F.; Crebelli, R.; Dusemund, B.; Filipič, M.; Frutos, M.J.; Galtier, P.; Gott, D.; et al. Re-evaluation of silicon dioxide (e 551) as a food additive. EFSA J. 2018, 16, e5088. [Google Scholar]
  17. Ehlerding, E.B.; Chen, F.; Cai, W.B. Biodegradable and renal clearable inorganic nanoparticles. Adv. Sci. 2016, 3, 1500223. [Google Scholar] [CrossRef]
  18. Mebert, A.M.; Baglole, C.J.; Desimone, M.F.; Maysinger, D. Nanoengineered silica: Properties, applications and toxicity. Food Chem. Toxicol. 2017, 109, 753–770. [Google Scholar] [CrossRef]
  19. Videira-Quintela, D.; Martin, O.; Montalvo, G. Emerging opportunities of silica-based materials within the food industry. Microchem. J. 2021, 167, 106318. [Google Scholar] [CrossRef]
  20. Watermann, A.; Brieger, J. Mesoporous silica nanoparticles as drug delivery vehicles in cancer. Nanomaterials 2017, 7, 189. [Google Scholar] [CrossRef] [Green Version]
  21. Cha, B.G.; Kim, J. Functional mesoporous silica nanoparticles for bio-imaging applications. WIREs Nanomed. Nanobiotechnol. 2019, 11, e1515. [Google Scholar] [CrossRef] [Green Version]
  22. Hasanzadeh, M.; Shadjou, N.; de la Guardia, M.; Eskandani, M.; Sheikhzadeh, P. Mesoporous silica-based materials for use in biosensors. TrAC Trends Anal. Chem. 2012, 33, 117–129. [Google Scholar] [CrossRef]
  23. Yanagisawa, T.; Shimizu, T.; Kuroda, K.; Kato, C. The preparation of alkyltrimethylammonium–kanemite complexes and their conversion to microporous materials. Bull. Chem. Soc. Jpn. 1990, 63, 988–992. [Google Scholar] [CrossRef] [Green Version]
  24. Kresge, C.T.; Leonowicz, M.E.; Roth, W.J.; Vartuli, J.C.; Beck, J.S. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 1992, 359, 710–712. [Google Scholar] [CrossRef]
  25. Beck, J.S.; Vartuli, J.C.; Roth, W.J.; Leonowicz, M.E.; Kresge, C.T.; Schmitt, K.D.; Chu, C.T.W.; Olson, D.H.; Sheppard, E.W.; Mccullen, S.B.; et al. A new family of mesoporous molecular sieves prepared with liquid crystal templates. J. Am. Chem. Soc. 1992, 114, 10834–10843. [Google Scholar] [CrossRef]
  26. Vartuli, J.C.; Roth, W.J.; Beck, J.S.; Mccullen, S.B.; Kresge, C.T. The synthesis and properties of m41s and related mesoporous materials. In Synthesis; Springer: Berlin/Heidelberg, Germany, 1998; pp. 97–119. [Google Scholar]
  27. Vartuli, J.C.; Schmitt, K.D.; Kresge, C.T.; Roth, W.J.; Leonowicz, M.E.; Mccullen, S.B.; Hellring, S.D.; Beck, J.S.; Schlenker, J.L.; Olson, D.H.; et al. Development of a formation mechanism for m41s materials. In Studies in Surface Science and Catalysis; Weitkamp, J., Karge, H.G., Pfeifer, H., Hölderich, W., Eds.; Elsevier: Amsterdam, The Netherlands, 1994; Volume 84, pp. 53–60. [Google Scholar]
  28. Vartuli, J.C.; Kresge, C.T.; Roth, W.J.; Mccullen, S.B.; Beck, J.S.; Schmitt, K.D.; Leonowicz, M.E.; Lutner, J.D.; Sheppard, E.W. Chapter 1-designed synthesis of mesoporous molecular sieve systems using surfactant-directing agents. In Advanced Catalysts and Nanostructured Materials; Moser, W.R., Ed.; Academic Press: San Diego, CA, USA, 1996; pp. 1–19. [Google Scholar]
  29. Beck, J.S.; Vartuli, J.C.; Kennedy, G.J.; Kresge, C.T.; Roth, W.J.; Schramm, S.E. Molecular or supramolecular templating: Defining the role of surfactant chemistry in the formation of microporous and mesoporous molecular sieves. Chem. Mat. 1994, 6, 1816–1821. [Google Scholar] [CrossRef]
  30. Zhang, L.; Jin, L.; Liu, B.; He, J. Templated growth of crystalline mesoporous materials: From soft/hard templates to colloidal templates. Front. Chem. 2019, 7, 22. [Google Scholar] [CrossRef]
  31. Li, W.; Zhao, D. An overview of the synthesis of ordered mesoporous materials. Chem. Commun. 2013, 49, 943–946. [Google Scholar] [CrossRef]
  32. Pal, N.; Bhaumik, A. Soft templating strategies for the synthesis of mesoporous materials: Inorganic, organic–inorganic hybrid and purely organic solids. Adv. Colloid Interface Sci. 2013, 189–190, 21–41. [Google Scholar] [CrossRef]
  33. Zhao, D.Y.; Feng, J.L.; Huo, Q.S.; Melosh, N.; Fredrickson, G.H.; Chmelka, B.F.; Stucky, G.D. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 1998, 279, 548–552. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Rivera-Muñoz, E.M.; Huirache-Acuña, R. Sol gel-derived SBA-16 mesoporous material. Int. J. Mol. Sci. 2010, 11, 3069–3086. [Google Scholar] [CrossRef] [Green Version]
  35. Rahmat, N.; Abdullah, A.Z.; Mohamed, A.R. A review: Mesoporous santa barbara amorphous-15, types, synthesis and its applications towards biorefinery production. Am. J. Appl. Sci. 2010, 7, 1579–1586. [Google Scholar] [CrossRef] [Green Version]
  36. Da Silva, F.D.C.M.; Costa, M.J.D.S.; Da Silva, L.K.R.; Batista, A.M.; Da Luz, G.E. Functionalization methods of SBA-15 mesoporous molecular sieve: A brief overview. SN Appl. Sci. 2019, 1, 654. [Google Scholar] [CrossRef] [Green Version]
  37. Verma, P.; Kuwahara, Y.; Mori, K.; Raja, R.; Yamashita, H. Functionalized mesoporous SBA-15 silica: Recent trends and catalytic applications. Nanoscale 2020, 12, 11333–11363. [Google Scholar] [CrossRef]
  38. Costa, J.A.S.; de Jesus, R.A.; Santos, D.O.; Neris, J.B.; Figueiredo, R.T.; Paranhos, C.M. Synthesis, functionalization, and environmental application of silica-based mesoporous materials of the M41s and SBA-n families: A review. J. Environ. Chem. Eng. 2021, 9, 105259. [Google Scholar] [CrossRef]
  39. Tanev, P.T.; Chibwe, M.; Pinnavaia, T.J. Titanium-containing mesoporous molecular sieves for catalytic oxidation of aromatic compounds. Nature 1994, 368, 321–323. [Google Scholar] [CrossRef] [PubMed]
  40. Inagaki, S.; Fukushima, Y.; Kuroda, K. Synthesis and characterization of highly ordered mesoporous material; Fsm-16, from a layered polysilicate. In Studies in Surface Science and Catalysis; Weitkamp, J., Karge, H.G., Pfeifer, H., Hölderich, W., Eds.; Elsevier: Amsterdam, The Netherlands, 1994; Volume 84, pp. 125–132. [Google Scholar]
  41. Bagshaw, S.A.; Prouzet, E.; Pinnavaia, T.J. Templating of mesoporous molecular sieves by nonionic polyethylene oxide surfactants. Science 1995, 269, 1242–1244. [Google Scholar] [CrossRef] [PubMed]
  42. Ryoo, R.; Kim, J.M.; Ko, C.H.; Shin, C.H. Disordered molecular sieve with branched mesoporous channel network. J. Phys. Chem. 1996, 100, 17718–17721. [Google Scholar] [CrossRef]
  43. Yu, C.Z.; Yu, Y.H.; Zhao, D.Y. Highly ordered large caged cubic mesoporous silica structures templated by triblock PEO–PBO–PEO copolymer. Chem. Commun. 2000, 7, 575–576. [Google Scholar] [CrossRef]
  44. Liu, Y.L.; Du, H.B.; Xiao, F.S.; Zhu, G.S.; Pang, W.Q. Synthesis and characterization of a novel microporous titanosilicate JLU-1. Chem. Mat. 2000, 12, 665–670. [Google Scholar] [CrossRef]
  45. Jansen, J.C.; Shan, Z.; Marchese, L.; Zhou, W.; Puil, N.V.D.; Maschmeyer, T. A new templating method for three-dimensional mesopore networks. Chem. Commun. 2001, 8, 713–714. [Google Scholar] [CrossRef]
  46. Jammaer, J.; Aerts, A.; D’Haen, J.; Seo, J.W.; Martens, J.A. Convenient synthesis of ordered mesoporous silica at room temperature and quasi-neutral ph. J. Mater. Chem. 2009, 19, 8290–8293. [Google Scholar] [CrossRef]
  47. Nandiyanto, A.B.D.; Kim, S.; Iskandar, F.; Okuyama, K. Synthesis of spherical mesoporous silica nanoparticles with nanometer-size controllable pores and outer diameters. Microporous Mesoporous Mat. 2009, 120, 447–453. [Google Scholar] [CrossRef]
  48. Grün, M.; Lauer, I.; Unger, K.K. The synthesis of micrometer- and submicrometer-size spheres of ordered mesoporous oxide MCM-41. Adv. Mater. 1997, 9, 254–257. [Google Scholar] [CrossRef]
  49. Cai, Q.; Luo, Z.S.; Pang, W.Q.; Fan, Y.W.; Chen, X.H.; Cui, F.Z. Dilute solution routes to various controllable morphologies of MCM-41 silica with a basic medium. Chem. Mat. 2001, 13, 258–263. [Google Scholar] [CrossRef]
  50. Kobler, J.; Möller, K.; Bein, T. Colloidal suspensions of functionalized mesoporous silica nanoparticles. ACS Nano 2008, 2, 791–799. [Google Scholar] [CrossRef]
  51. Möller, K.; Kobler, J.; Bein, T. Colloidal suspensions of mercapto-functionalized nanosized mesoporous silica. J. Mater. Chem. 2007, 17, 624–631. [Google Scholar] [CrossRef]
  52. Möller, K.; Kobler, J.; Bein, T. Colloidal suspensions of nanometer-sized mesoporous silica. Adv. Funct. Mater. 2007, 17, 605–612. [Google Scholar] [CrossRef]
  53. Qiu, P.P.; Ma, B.; Hung, C.T.; Li, W.; Zhao, D.Y. Spherical mesoporous materials from single to multilevel architectures. Acc. Chem. Res. 2019, 52, 2928–2938. [Google Scholar] [CrossRef]
  54. Lin, H.P.; Cheng, Y.R.; Mou, C.Y. Hierarchical order in hollow spheres of mesoporous silicates. Chem. Mat. 1998, 10, 3772–3776. [Google Scholar] [CrossRef]
  55. Li, Y.S.; Shi, J.L.; Hua, Z.L.; Chen, H.R.; Ruan, M.L.; Yan, D.S. Hollow spheres of mesoporous aluminosilicate with a three-dimensional pore network and extraordinarily high hydrothermal stability. Nano Lett. 2003, 3, 609–612. [Google Scholar] [CrossRef]
  56. Zhu, Y.F.; Shi, J.L.; Shen, W.H.; Chen, H.R.; Dong, X.P.; Ruan, M.L. Preparation of novel hollow mesoporous silica spheres and their sustained-release property. Nanotechnology 2005, 16, 2633. [Google Scholar] [CrossRef]
  57. Shen, D.K.; Yang, J.P.; Li, X.M.; Zhou, L.; Zhang, R.Y.; Li, W.; Chen, L.; Wang, R.; Zhang, F.; Zhao, D.Y. Biphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheres. Nano Lett. 2014, 14, 923–932. [Google Scholar] [CrossRef] [PubMed]
  58. Malgras, V.; Ji, Q.M.; Kamachi, Y.; Mori, T.; Shieh, F.K.; Wu, K.C.W.; Ariga, K.; Yamauchi, Y. Templated synthesis for nanoarchitectured porous materials. Bull. Chem. Soc. Jpn. 2015, 88, 1171–1200. [Google Scholar] [CrossRef]
  59. Pérez-Page, M.; Yu, E.; Li, J.; Rahman, M.; Dryden, D.M.; Vidu, R.; Stroeve, P. Template-based syntheses for shape controlled nanostructures. Adv. Colloid Interface Sci. 2016, 234, 51–79. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Kaur, A.; Bajaj, B.; Kaushik, A.; Saini, A.; Sud, D. A review on template assisted synthesis of multi-functional metal oxide nanostructures: Status and prospects. Mater. Sci. Eng. B 2022, 286, 116005. [Google Scholar] [CrossRef]
  61. Hoffmann, F.; Cornelius, M.; Morell, J.; Fröba, M. Silica-based mesoporous organic–inorganic hybrid materials. Angew. Chem. Int. Ed. 2006, 45, 3216–3251. [Google Scholar] [CrossRef]
  62. Mou, C.Y.; Lin, H.P. Control of morphology in synthesizing mesoporous silica. Pure Appl. Chem. 2000, 72, 137–146. [Google Scholar] [CrossRef] [Green Version]
  63. Narayan, R.; Nayak, U.Y.; Raichur, A.M.; Garg, S. Mesoporous silica nanoparticles: A comprehensive review on synthesis and recent advances. Pharmaceutics 2018, 10, 118. [Google Scholar] [CrossRef] [Green Version]
  64. Martens, J.A.; Jammaer, J.; Bajpe, S.; Aerts, A.; Lorgouilloux, Y.; Kirschhock, C.E.A. Simple synthesis recipes of porous materials. Microporous Mesoporous Mat. 2011, 140, 2–8. [Google Scholar] [CrossRef]
  65. Lawrence, C.; Thielemans, W.; Mokaya, R. One step room temperature synthesis of ordered mesoporous silica SBA-15 mediated by cellulose nanoparticles. J. Mater. Chem. 2010, 20, 320–325. [Google Scholar] [CrossRef]
  66. Matijasic, A.; Voegtlin, A.C.; Patarin, J.; Guth, J.L.; Huve, L. Room-temperature synthesis of silicate mesoporous materials. An in situ study of the lamellar to hexagonal phase transition. Chem. Commun. 1996, 10, 1123–1124. [Google Scholar] [CrossRef]
  67. Huo, Q.S.; Margolese, D.I.; Ciesla, U.; Feng, P.Y.; Gier, T.E.; Sieger, P.; Leon, R.; Petroff, P.M.; Schüth, F.; Stucky, G.D. Generalized synthesis of periodic surfactant/inorganic composite materials. Nature 1994, 368, 317–321. [Google Scholar] [CrossRef]
  68. Yu, Q.Y.; Hui, J.F.; Wang, P.P.; Xu, B.; Zhuang, J.; Wang, X. Hydrothermal synthesis of mesoporous silica spheres: Effect of the cooling process. Nanoscale 2012, 4, 7114–7120. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  69. Lawrence, G.; Baskar, A.V.; El-Newehy, M.H.; Cha, W.S.; Al-Deyab, S.S.; Vinu, A. Quick high-temperature hydrothermal synthesis of mesoporous materials with 3d cubic structure for the adsorption of lysozyme. Sci. Technol. Adv. Mater. 2015, 16, 24806. [Google Scholar] [CrossRef] [PubMed]
  70. Pan, D.H.; Yuan, P.; Zhao, L.Z.; Liu, N.; Zhou, L.; Wei, G.F.; Zhang, J.; Ling, Y.C.; Fan, Y.; Wei, B.Y.; et al. New understanding and simple approach to synthesize highly hydrothermally stable and ordered mesoporous materials. Chem. Mat. 2009, 21, 5413–5425. [Google Scholar] [CrossRef]
  71. Han, Y.; Li, D.F.; Zhao, L.; Song, J.W.; Yang, X.Y.; Li, N.; Di, Y.; Li, C.J.; Wu, S.; Xu, X.Z.; et al. High-temperature generalized synthesis of stable ordered mesoporous silica-based materials by using fluorocarbon–hydrocarbon surfactant mixtures. Angew. Chem. Int. Ed. 2003, 42, 3633–3637. [Google Scholar] [CrossRef] [PubMed]
  72. Yang, G.J.; Park, S.J. Conventional and microwave hydrothermal synthesis and application of functional materials: A review. Materials 2019, 12, 1177. [Google Scholar] [CrossRef] [Green Version]
  73. Díaz De Greñu, B.; de Los Reyes, R.; Costero, A.M.; Amorós, P.; Ros-Lis, J.V. Recent progress of microwave-assisted synthesis of silica materials. Nanomaterials 2020, 10, 1092. [Google Scholar] [CrossRef]
  74. Fantini, M.C.A.; Matos, J.R.; Silva, L.C.C.D.; Mercuri, L.P.; Chiereci, G.O.; Celer, E.B.; Jaroniec, M. Ordered mesoporous silica: Microwave synthesis. Mater. Sci. Eng. B 2004, 112, 106–110. [Google Scholar] [CrossRef]
  75. Tendeloo, G.V.; Lebedev, O.I.; Collart, O.; Cool, P.; Vansant, E.F. Structure of nanoscale mesoporous silica spheres? J. Phys. Condens. Matter 2003, 15, S3037. [Google Scholar] [CrossRef]
  76. Yano, K.; Fukushima, Y. Synthesis of mono-dispersed mesoporous silica spheres with highly ordered hexagonal regularity using conventional alkyltrimethylammonium halide as a surfactant. J. Mater. Chem. 2004, 14, 1579–1584. [Google Scholar] [CrossRef]
  77. Garrido, M.D.; El Haskouri, J.; Vie, D.; Beltrán, A.; Ros-Lis, J.V.; Marcos, M.D.; Moliner, N.; Amorós, P. Generalized “one-pot” preparative strategy to obtain highly functionalized silica-based mesoporous spherical particles. Microporous Mesoporous Mat. 2022, 337, 111942. [Google Scholar] [CrossRef]
  78. Pan, L.M.; He, Q.J.; Liu, J.N.; Chen, Y.; Ma, M.; Zhang, L.L.; Shi, J.L. Nuclear-targeted drug delivery of tat peptide-conjugated monodisperse mesoporous silica nanoparticles. J. Am. Chem. Soc. 2012, 134, 5722–5725. [Google Scholar] [CrossRef]
  79. Zhou, Y.M.; Xu, Q.N.; Li, C.H.; Chen, Y.Q.; Zhang, Y.L.; Lu, B. Hollow mesoporous silica nanoparticles as nanocarriers employed in cancer therapy: A review. Front. Mater. Sci. 2020, 14, 373–386. [Google Scholar] [CrossRef]
  80. Sunwoo, Y.; Karunakaran, G.; Cho, E.B. Hollow mesoporous silica nanospheres using pentablock copolymer micelle templates. Ceram. Int. 2021, 47, 13351–13362. [Google Scholar] [CrossRef]
  81. Teng, Z.G.; Han, Y.D.; Li, J.; Yan, F.; Yang, W.S. Preparation of hollow mesoporous silica spheres by a sol–gel/emulsion approach. Microporous Mesoporous Mat. 2010, 127, 67–72. [Google Scholar] [CrossRef]
  82. Han, L.; Gao, C.B.; Wu, X.W.; Chen, Q.R.; Shu, P.; Ding, Z.G.; Che, S.A. Anionic surfactants templating route for synthesizing silica hollow spheres with different shell porosity. Solid State Sci. 2011, 13, 721–728. [Google Scholar] [CrossRef]
  83. Khoeini, M.; Najafi, A.; Rastegar, H.; Amani, M. Improvement of hollow mesoporous silica nanoparticles synthesis by hard-templating method via ctab surfactant. Ceram. Int. 2019, 45, 12700–12707. [Google Scholar] [CrossRef]
  84. Fang, X.L.; Chen, C.; Liu, Z.H.; Liu, P.X.; Zheng, N.F. A cationic surfactant assisted selective etching strategy to hollow mesoporous silica spheres. Nanoscale 2011, 3, 1632–1639. [Google Scholar] [CrossRef]
  85. Rahman, Z.U.; Wei, N.; Li, Z.X.; Sun, W.X.; Wang, D.A. Preparation of hollow mesoporous silica nanospheres: Controllable template synthesis and their application in drug delivery. New J. Chem. 2017, 41, 14122–14129. [Google Scholar] [CrossRef]
  86. Wu, M.Y.; Chen, Y.; Zhang, L.X.; Li, X.Y.; Cai, X.J.; Du, Y.Y.; Zhang, L.L.; Shi, J.L. A salt-assisted acid etching strategy for hollow mesoporous silica/organosilica for ph-responsive drug and gene co-delivery. J. Mat. Chem. B 2015, 3, 766–775. [Google Scholar] [CrossRef] [PubMed]
  87. Liu, S.; Dun, C.C.; Chen, J.J.; Rao, S.; Shah, M.; Wei, J.L.; Chen, K.W.; Xuan, Z.X.; Kyriakidou, E.A.; Urban, J.J.; et al. A general route to flame aerosol synthesis and in situ functionalization of mesoporous silica. Angew. Chem. Int. Ed. 2022, 61, e202206870. [Google Scholar]
  88. Zhang, H.C.; Wang, X.D.; Wang, P.Y.; Liu, R.; Hou, X.M.; Cao, W.; Zhong, R.; Liu, X.L.; Zhang, Y. One-pot synthesis of biodegradable polydopamine-doped mesoporous silica nanocomposites (PMSNs) as ph-sensitive targeting drug nanocarriers for synergistic chemo-photothermal therapy. RSC Adv. 2018, 8, 37433–37440. [Google Scholar] [CrossRef] [Green Version]
  89. Wang, W.Y.; Chen, Y.; Chen, A.L.; Ma, X.Y. Composite particles with dendritic mesoporous-silica cores and nano-sized CeO2 shells and their application to abrasives in chemical mechanical polishing. Mater. Chem. Phys. 2020, 240, 122279. [Google Scholar] [CrossRef]
  90. Feng, J.Q.; Feng, J.J.; Loussala, H.M.; Han, S.; Ji, X.P.; Li, C.Y.; Sun, H.L.; Sun, M. Dendritic mesoporous silica nanospheres@porous carbon for in-tube solid-phase microextraction to detect polycyclic aromatic hydrocarbons in tea beverages. Food Chem. 2021, 364, 130379. [Google Scholar] [CrossRef]
  91. Zhang, Y.; Yue, Q.; Zagho, M.M.; Zhang, J.; Elzatahry, A.A.; Jiang, Y.J.; Deng, Y.H. Core–shell magnetic mesoporous silica microspheres with large mesopores for enzyme immobilization in biocatalysis. ACS Appl. Mater. Interfaces 2019, 11, 10356–10363. [Google Scholar] [CrossRef] [PubMed]
  92. Dogra, A.R.; Sharma, V.; Gahrotra, R.; Kumar, P. Evaporation induced self-assembly of silica nanoparticles on ito substrates in a confined cell for vertical alignment of liquid crystals and performance analysis. Colloids Surf. A Physicochem. Eng. Asp. 2022, 642, 128712. [Google Scholar] [CrossRef]
  93. Mora-Raimundo, P.; Lozano, D.; Benito, M.; Mulero, F.; Manzano, M.; Vallet-Regí, M. Osteoporosis remission and new bone formation with mesoporous silica nanoparticles. Adv. Sci. 2021, 8, 2101107. [Google Scholar] [CrossRef] [PubMed]
  94. Jiang, H.; Guo, Y.D.; Wei, C.Y.; Hu, P.; Shi, J.L. Nanocatalytic innate immunity activation by mitochondrial DNA oxidative damage for tumor-specific therapy. Adv. Mater. 2021, 33, 2008065. [Google Scholar] [CrossRef]
  95. Koohi Moftakhari Esfahani, M.; Alavi, S.E.; Cabot, P.J.; Islam, N.; Izake, E.L. Application of mesoporous silica nanoparticles in cancer therapy and delivery of repurposed anthelmintics for cancer therapy. Pharmaceutics 2022, 14, 1579. [Google Scholar] [CrossRef]
  96. Huang, Y.N.; Du, Z.Q.; Bao, G.C.; Fang, G.C.; Cappadona, M.; Mcclements, L.; Tuch, B.E.; Lu, H.X.; Xu, X.X. Smart drug-delivery system of upconversion nanoparticles coated with mesoporous silica for controlled release. Pharmaceutics 2023, 15, 89. [Google Scholar] [CrossRef]
  97. Jafari, S.; Derakhshankhah, H.; Alaei, L.; Fattahi, A.; Varnamkhasti, B.S.; Saboury, A.A. Mesoporous silica nanoparticles for therapeutic/diagnostic applications. Biomed. Pharmacother. 2019, 109, 1100–1111. [Google Scholar] [CrossRef] [PubMed]
  98. Meng, H.; Mao, J.Q.; Liu, C.S.; Wei, J. Application of mesoporous molecular sieves in medicine. J. Pharm. Pract. Serv. 2012, 30, 262–265. [Google Scholar]
  99. Asefa, T.; Tao, Z. Biocompatibility of mesoporous silica nanoparticles. Chem. Res. Toxicol. 2012, 25, 2265–2284. [Google Scholar] [CrossRef] [PubMed]
  100. Vallet-Regi, M.; Rámila, A.; Del Real, R.P.; Pérez-Pariente, J. A new property of MCM-41: Drug delivery system. Chem. Mat. 2001, 13, 308–311. [Google Scholar] [CrossRef]
  101. Poostforooshan, J.; Belbekhouche, S.; Shaban, M.; Alphonse, V.; Habert, D.; Bousserrhine, N.; Courty, J.; Weber, A.P. Aerosol-assisted synthesis of tailor-made hollow mesoporous silica microspheres for controlled release of antibacterial and anticancer agents. ACS Appl. Mater. Interfaces 2020, 12, 6885–6898. [Google Scholar] [CrossRef]
  102. Zhu, Y.F.; Shi, J.L.; Chen, H.R.; Shen, W.H.; Dong, X.P. A facile method to synthesize novel hollow mesoporous silica spheres and advanced storage property. Microporous Mesoporous Mat. 2005, 84, 218–222. [Google Scholar] [CrossRef]
  103. Bakhshian Nik, A.; Zare, H.; Razavi, S.; Mohammadi, H.; Torab Ahmadi, P.; Yazdani, N.; Bayandori, M.; Rabiee, N.; Izadi Mobarakeh, J. Smart drug delivery: Capping strategies for mesoporous silica nanoparticles. Microporous Mesoporous Mat. 2020, 299, 110115. [Google Scholar] [CrossRef]
  104. Alyassin, Y.; Sayed, E.G.; Mehta, P.; Ruparelia, K.; Arshad, M.S.; Rasekh, M.; Shepherd, J.; Kucuk, I.; Wilson, P.B.; Singh, N.; et al. Application of mesoporous silica nanoparticles as drug delivery carriers for chemotherapeutic agents. Drug Discov. Today 2020, 25, 1513–1520. [Google Scholar] [CrossRef] [PubMed]
  105. Li, Y.H.; Li, N.; Pan, W.; Yu, Z.Z.; Yang, L.M.; Tang, B. Hollow mesoporous silica nanoparticles with tunable structures for controlled drug delivery. ACS Appl. Mater. Interfaces 2017, 9, 2123–2129. [Google Scholar] [CrossRef]
  106. Manzari, M.T.; Shamay, Y.; Kiguchi, H.; Rosen, N.; Scaltriti, M.; Heller, D.A. Targeted drug delivery strategies for precision medicines. Nat. Rev. Mater. 2021, 6, 351–370. [Google Scholar] [CrossRef]
  107. Bharti, C.; Nagaich, U.; Pal, A.K.; Gulati, N. Mesoporous silica nanoparticles in target drug delivery system: A review. Int. J. Pharm. Investig. 2015, 5, 124–133. [Google Scholar] [CrossRef] [Green Version]
  108. Kumari, P.; Ghosh, B.; Biswas, S. Nanocarriers for cancer-targeted drug delivery. J. Drug Target. 2016, 24, 179–191. [Google Scholar] [CrossRef] [PubMed]
  109. Chen, F.; Hong, H.; Shi, S.X.; Goel, S.; Valdovinos, H.F.; Hernandez, R.; Theuer, C.P.; Barnhart, T.E.; Cai, W.B. Engineering of hollow mesoporous silica nanoparticles for remarkably enhanced tumor active targeting efficacy. Sci. Rep. 2014, 4, 5080. [Google Scholar] [CrossRef] [Green Version]
  110. Müller, J.; Wunder, A.; Licha, K. Optical imaging. In Molecular Imaging in Oncology; Schober, O., Riemann, B., Eds.; Springer: Berlin/Heidelberg, Germany, 2013; pp. 221–246. [Google Scholar]
  111. Balas, C. Review of biomedical optical imaging—A powerful, non-invasive, non-ionizing technology for improving in vivo diagnosis. Meas. Sci. Technol. 2009, 20, 104020. [Google Scholar] [CrossRef]
  112. Bocklitz, T.; Silge, A.; Bae, H.; Rodewald, M.; Legesse, F.B.; Meyer, T.; Popp, J. Non-invasive imaging techniques: From histology to in vivo imaging. In Molecular Imaging in Oncology; Schober, O., Kiessling, F., Debus, J., Eds.; Springer International Publishing: Cham, Switzerland, 2020; pp. 795–812. [Google Scholar]
  113. Shin, J.H.; Moon, B.S.; Kim, D.H. Upconversion nanoparticles coated with mesoporous silica nanoshells loaded with dyes for fine-tuned multicolor emission in bioimaging applications. ACS Appl. Nano Mater. 2022, 5, 3541–3547. [Google Scholar] [CrossRef]
  114. Yuan, D.H.; Ellis, C.M.; Davis, J.J. Mesoporous silica nanoparticles in bioimaging. Materials 2020, 13, 3795. [Google Scholar] [CrossRef] [PubMed]
  115. Du, X.; Li, X.Y.; Xiong, L.; Zhang, X.J.; Kleitz, F.; Qiao, S.Z. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery. Biomaterials 2016, 91, 90–127. [Google Scholar] [CrossRef]
  116. Wang, Y.; Gu, H.C. Core–shell-type magnetic mesoporous silica nanocomposites for bioimaging and therapeutic agent delivery. Adv. Mater. 2015, 27, 576–585. [Google Scholar] [CrossRef]
  117. Kim, H.; Rao, B.A.; Jeong, J.; Angupillai, S.; Choi, J.S.; Nam, J.O.; Lee, C.S.; Son, Y.A. A rhodamine scaffold immobilized onto mesoporous silica as a fluorescent probe for the detection of Fe (III) and applications in bio-imaging and microfluidic chips. Sens. Actuators B Chem. 2016, 224, 404–412. [Google Scholar] [CrossRef]
  118. Wu, Y.X.; Zhang, D.L.; Hu, X.X.; Peng, R.Z.; Li, J.B.; Zhang, X.B.; Tan, W.H. Multicolor two-photon nanosystem for multiplexed intracellular imaging and targeted cancer therapy. Angew. Chem. Int. Ed. 2021, 60, 12569–12576. [Google Scholar] [CrossRef]
  119. Li, S.; Zhang, Y.; He, X.W.; Li, W.Y.; Zhang, Y.K. Multifunctional mesoporous silica nanoplatform based on silicon nanoparticles for targeted two-photon-excited fluorescence imaging-guided chemo/photodynamic synergetic therapy in vitro. Talanta 2020, 209, 120552. [Google Scholar] [CrossRef]
  120. Gong, P.W.; Zhang, L.; Yuan, X.A.; Liu, X.C.; Diao, X.L.; Zhao, Q.; Tian, Z.Z.; Sun, J.; Liu, Z.; You, J.M. Multifunctional fluorescent pegylated fluorinated graphene for targeted drug delivery: An experiment and dft study. Dyes Pigment. 2019, 162, 573–582. [Google Scholar] [CrossRef]
  121. Gao, Y.; Zhong, S.L.; Xu, L.F.; He, S.H.; Dou, Y.M.; Zhao, S.N.; Chen, P.; Cui, X.J. Mesoporous silica nanoparticles capped with graphene quantum dots as multifunctional drug carriers for photo-thermal and redox-responsive release. Microporous Mesoporous Mat. 2019, 278, 130–137. [Google Scholar] [CrossRef]
  122. Yan, H.; Dong, J.T.; Huang, X.; Du, X.Z. Protein-gated upconversion nanoparticle-embedded mesoporous silica nanovehicles via diselenide linkages for drug release tracking in real time and tumor chemotherapy. ACS Appl. Mater. Interfaces 2021, 13, 29070–29082. [Google Scholar] [CrossRef]
  123. Du, M.; Chen, Y.H.; Tu, J.W.; Liufu, C.; Yu, J.S.; Yuan, Z.; Gong, X.J.; Chen, Z.Y. Ultrasound responsive magnetic mesoporous silica nanoparticle-loaded microbubbles for efficient gene delivery. ACS Biomater. Sci. Eng. 2020, 6, 2904–2912. [Google Scholar] [CrossRef] [PubMed]
  124. Mura, S.; Nicolas, J.; Couvreur, P. Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 2013, 12, 991–1003. [Google Scholar] [CrossRef] [PubMed]
  125. Lin, F.C.; Xie, Y.J.; Deng, T.; Zink, J.I. Magnetism, ultrasound, and light-stimulated mesoporous silica nanocarriers for theranostics and beyond. J. Am. Chem. Soc. 2021, 143, 6025–6036. [Google Scholar] [CrossRef] [PubMed]
  126. Li, X.C.; Xie, C.; Xia, H.S.; Wang, Z.H. Ph and ultrasound dual-responsive polydopamine-coated mesoporous silica nanoparticles for controlled drug delivery. Langmuir 2018, 34, 9974–9981. [Google Scholar] [CrossRef]
  127. Pourshahrestani, S.; Kadri, N.A.; Zeimaran, E.; Towler, M.R. Well-ordered mesoporous silica and bioactive glasses: Promise for improved hemostasis. Biomater. Sci. 2019, 7, 31–50. [Google Scholar] [CrossRef]
  128. Sung, Y.K.; Lee, D.R.; Chung, D.J. Advances in the development of hemostatic biomaterials for medical application. Biomater. Res. 2021, 25, 37. [Google Scholar] [CrossRef] [PubMed]
  129. Wang, Y.F.; Yin, M.L.; Zheng, X.H.; Li, W.; Ren, X.H. Chitosan/mesoporous silica hybrid aerogel with bactericidal properties as hemostatic material. Eur. Polym. J. 2021, 142, 110132. [Google Scholar] [CrossRef]
  130. Mohamed, S.S.Y.; Gambino, A.; Banchero, M.; Ronchetti, S.; Manna, L.; Cavalli, R.; Onida, B. Tranexamic acid-loaded mesoporous silica microspheres as a hemostatic material. Mater. Today Commun. 2023, 34, 105198. [Google Scholar]
  131. Hooshmand, S.; Mollazadeh, S.; Akrami, N.; Ghanad, M.; El-Fiqi, A.; Baino, F.; Nazarnezhad, S.; Kargozar, S. Mesoporous silica nanoparticles and mesoporous bioactive glasses for wound management: From skin regeneration to cancer therapy. Materials 2021, 14, 3337. [Google Scholar] [CrossRef] [PubMed]
  132. Zhang, Z.R.; Liu, T.; Qi, Z.H.; Li, F.; Yang, K.; Ding, S.; Lin, S.; Tian, F. Fabrication of effective mesoporous silica materials for emergency hemostasis application. Silicon 2022, 14, 10521–10534. [Google Scholar] [CrossRef]
  133. Chen, J.W.; Qiu, L.P.; Li, Q.L.; Ai, J.; Liu, H.Q.; Chen, Q.H. Rapid hemostasis accompanied by antibacterial action of calcium crosslinking tannic acid-coated mesoporous silica/silver janus nanoparticles. Mater. Sci. Eng. C 2021, 123, 111958. [Google Scholar] [CrossRef] [PubMed]
Molecules 28 02013 g001 550
Figure 1. Synthesis process, mechanism of interfacial growth, and representative micrographs of the dendritic mesoporous silica nanospheres. Reproduced with permission from Ref. [57], Copyright 2014, American Chemical Society.
Figure 1. Synthesis process, mechanism of interfacial growth, and representative micrographs of the dendritic mesoporous silica nanospheres. Reproduced with permission from Ref. [57], Copyright 2014, American Chemical Society.
Molecules 28 02013 g001
Molecules 28 02013 g002 550
Figure 2. Mechanism of formation of MCM-41. Reproduced with permission from Ref. [63], Copyright 2018, MDPI.
Figure 2. Mechanism of formation of MCM-41. Reproduced with permission from Ref. [63], Copyright 2018, MDPI.
Molecules 28 02013 g002
Molecules 28 02013 g003 550
Figure 3. One-pot preparative strategy and representative micrographs of the mesoporous silica functionalized with homogeneous distributed elements (Fe, Zn, Al, or Ti). Reproduced with permission from Ref. [77], Copyright 2022, Elsevier.
Figure 3. One-pot preparative strategy and representative micrographs of the mesoporous silica functionalized with homogeneous distributed elements (Fe, Zn, Al, or Ti). Reproduced with permission from Ref. [77], Copyright 2022, Elsevier.
Molecules 28 02013 g003
Molecules 28 02013 g004 550
Figure 4. (A) Schematic diagram of the procedures for developing mesoporous silica nanoparticles. (B) Schematic illustration of transport of DOX-loaded particles across the nuclear membrane. (C) TEM images of mesoporous silica nanoparticles with sizes of (a) 25, (b) 50, (c) 67, and (d) 105 nm. Scale bars: 100 nm. Reproduced with permission from Ref. [78], Copyright 2012, American Chemical Society.
Figure 4. (A) Schematic diagram of the procedures for developing mesoporous silica nanoparticles. (B) Schematic illustration of transport of DOX-loaded particles across the nuclear membrane. (C) TEM images of mesoporous silica nanoparticles with sizes of (a) 25, (b) 50, (c) 67, and (d) 105 nm. Scale bars: 100 nm. Reproduced with permission from Ref. [78], Copyright 2012, American Chemical Society.
Molecules 28 02013 g004
Molecules 28 02013 g005 550
Figure 5. (Up) Schematic illustration of the structural difference between the sSiO2 core and mSiO2 (moSiO2) shell, and the synthetic procedure for HMOVs employing the acid etchants (H2SO4 and Na2SO4). (Down) TEM images of RMOVs converted from sSiO2@moSiO2 by H2SO4 plus Na2SO4 etching for varied hydrothermal time durations. Reproduced with permission from Ref. [86], Copyright 2015, Royal Society of Chemistry.
Figure 5. (Up) Schematic illustration of the structural difference between the sSiO2 core and mSiO2 (moSiO2) shell, and the synthetic procedure for HMOVs employing the acid etchants (H2SO4 and Na2SO4). (Down) TEM images of RMOVs converted from sSiO2@moSiO2 by H2SO4 plus Na2SO4 etching for varied hydrothermal time durations. Reproduced with permission from Ref. [86], Copyright 2015, Royal Society of Chemistry.
Molecules 28 02013 g005
Molecules 28 02013 g006 550
Figure 6. Schematic illustration of the preparation of hollow mesoporous silica used for drug loading and drug releasing. Reproduced with permission from Ref. [105], Copyright 2017, American Chemical Society.
Figure 6. Schematic illustration of the preparation of hollow mesoporous silica used for drug loading and drug releasing. Reproduced with permission from Ref. [105], Copyright 2017, American Chemical Society.
Molecules 28 02013 g006
Molecules 28 02013 g007 550
Figure 7. (a) Scheme of surface engineering hollow mesoporous silica nanoparticles; (b) TEM images of the corresponding nanoparticles. Reproduced with permission from Ref. [109], Copyright 2014, Springer Nature.
Figure 7. (a) Scheme of surface engineering hollow mesoporous silica nanoparticles; (b) TEM images of the corresponding nanoparticles. Reproduced with permission from Ref. [109], Copyright 2014, Springer Nature.
Molecules 28 02013 g007
Molecules 28 02013 g008 550
Figure 8. (a) Diagram illustrating the synthetic route of MTP–MSNs. (b) Design strategy of the MTP–MSNs@DOX@APTAMER theranostic nanosystem and working mechanism for controlled release of therapeutic agents. Reproduced with permission from Ref. [118], Copyright 2021, John Wiley and Sons.
Figure 8. (a) Diagram illustrating the synthetic route of MTP–MSNs. (b) Design strategy of the MTP–MSNs@DOX@APTAMER theranostic nanosystem and working mechanism for controlled release of therapeutic agents. Reproduced with permission from Ref. [118], Copyright 2021, John Wiley and Sons.
Molecules 28 02013 g008
Molecules 28 02013 g009 550
Figure 9. Creation of nanovehicles of protein-gated UCNP@mSiO2 via Se−Se linkages to track drug release in real time in response to several stimuli. Reproduced with permission from Ref. [122], Copyright 2021, American Chemical Society.
Figure 9. Creation of nanovehicles of protein-gated UCNP@mSiO2 via Se−Se linkages to track drug release in real time in response to several stimuli. Reproduced with permission from Ref. [122], Copyright 2021, American Chemical Society.
Molecules 28 02013 g009
Molecules 28 02013 g010 550
Figure 10. Schematic representation of MSN@DOX−PDA and its pH/HIFU dual-responsive release performances. Reproduced with permission from Ref. [126], Copyright 2021, American Chemical Society.
Figure 10. Schematic representation of MSN@DOX−PDA and its pH/HIFU dual-responsive release performances. Reproduced with permission from Ref. [126], Copyright 2021, American Chemical Society.
Molecules 28 02013 g010
Molecules 28 02013 g011 550
Figure 11. The potential (a) hemostatic and (b) antibacterial mechanism of Ca-TA-MSN@Ag. Reproduced with permission from Ref. [133], Copyright 2021, Elsevier.
Figure 11. The potential (a) hemostatic and (b) antibacterial mechanism of Ca-TA-MSN@Ag. Reproduced with permission from Ref. [133], Copyright 2021, Elsevier.
Molecules 28 02013 g011
Table
Table 1. Information about the origin of several important mesoporous silica families.
Table 1. Information about the origin of several important mesoporous silica families.
NameOrigin of NameFirst ReportReferences
M41SMobil Composition of Matter No. 41Kresge et al./1992[24,25]
HMSHexagonal Mesoporous SilicaTanev et al./1994[39]
FSMFolded Sheets Mesoporous MaterialsInagaki et al./1994[40]
MSUMichigan State UniversityBagshaw et al./1995[41]
KITKorea AdvancedInstitute of Science and TechnologyRyoo et al./1996[42]
SBASanta Barbara AmorphousZhao et al./1998[33]
FDUFudan UniversityYu et al./2000[43]
JLUJiLin UniversityLiu et al./2000[44]
TUDTechnische Universiteit DelftJansen et al./2001[45]
COKCentrum voor Oppervlaktechemie en KatalyseJammaer et al./2008[46]
HMMHiroshima Mesoporous MaterialNandiyanto et al./2009[47]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Li, Q.; Zhou, Y. Brief History, Preparation Method, and Biological Application of Mesoporous Silica Molecular Sieves: A Narrative Review. Molecules 2023, 28, 2013. https://doi.org/10.3390/molecules28052013

AMA Style

Li Q, Zhou Y. Brief History, Preparation Method, and Biological Application of Mesoporous Silica Molecular Sieves: A Narrative Review. Molecules. 2023; 28(5):2013. https://doi.org/10.3390/molecules28052013

Chicago/Turabian Style

Li, Qiuping, and You Zhou. 2023. "Brief History, Preparation Method, and Biological Application of Mesoporous Silica Molecular Sieves: A Narrative Review" Molecules 28, no. 5: 2013. https://doi.org/10.3390/molecules28052013

APA Style

Li, Q., & Zhou, Y. (2023). Brief History, Preparation Method, and Biological Application of Mesoporous Silica Molecular Sieves: A Narrative Review. Molecules, 28(5), 2013. https://doi.org/10.3390/molecules28052013

Article Metrics

Back to TopTop